• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ANTEIS S.A. BELOTERO BALANCE; IMPLANT, DERMAL, FOR AESTHETIC USE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ANTEIS S.A. BELOTERO BALANCE; IMPLANT, DERMAL, FOR AESTHETIC USE Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Bruise/Contusion (1754)
Event Type  Injury  
Manufacturer Narrative
This case was assessed as reportable to the fda as the event, progressive bruising (injection site bruising), was deemed to meet serious injury criteria of necessitated medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure.The device history record could not be reviewed as the lot number was not reported.Literature citation: jagus d, skrzypek e, migda b, wozniak w, mlosek rk: usefulness of doppler sonography in aesthetic medicine.J ultrason 2020; 20: e268-e272.Doi: 10.15557/jou.2020.0047.
 
Event Description
This mdr is related to mdr 3013840437-2021-00026 and 3013840437-2021-00027 referring to the same literature article.This is a literature report from a retrospective study aimed to assess the usefulness of high frequency doppler imaging in the diagnosis of vascular complications after augmentation procedures with tissue fillers.This literature report from poland concerns a (b)(6) female patient.She was injected with hyaluronic acid, into the ridge and the bridge of the nose.Five hours after the treatment with hyaluronic acid, the patient developed reddening and progressive bruising of the nasal and frontal region.Corrective treatment included 1300 units of hyaluronidase, vitamin c, dexamethason, ciprofloxacin and massage.The appearance of the skin improved and a follow-up ultrasound was recommended.No hyaluronic acid deposits were detected on ultrasound, indicating their effective dissolution.The flow in the dorsal nasal arteries was maintained.The outcome of the event was considered as resolved.In the opinion of the author, the skin ultrasound with doppler options is a useful tool in the diagnosis of aesthetic medicine complications.There is a growing interest in dermal ultrasonography among both doctors specialized in dermatology and aesthetic medicine, as well as patients.This creates a need to constantly incorporate new imaging techniques and functions featured by modern ultrasound scanners into dermal ultrasonography.In addition to standard assessment of the epidermis, dermis and subcutaneous tissue, imaging of the vascularity of the examined area should be a crucial element of each examination.Imaging of skin vessels is currently rare, although it has been shown to be extremely useful.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BELOTERO BALANCE
Type of Device
IMPLANT, DERMAL, FOR AESTHETIC USE
Manufacturer (Section D)
ANTEIS S.A.
18, chemin des aulx
1228 plan-les-ouates
geneva,
SZ 
Manufacturer (Section G)
ANTEIS, S.A.
18, chemin des aulx
1228 plan-les-ouates
geneva,
SZ  
Manufacturer Contact
product safety
6501 six forks rd
raleigh, NC 27615
9195828000
MDR Report Key11351017
MDR Text Key242883399
Report Number3013840437-2021-00028
Device Sequence Number1
Product Code LMH
Combination Product (y/n)Y
Reporter Country CodePL
PMA/PMN Number
P090016
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,l
Reporter Occupation Other
Type of Report Initial
Report Date 02/19/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/19/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator No Information
Date Manufacturer Received01/27/2021
Is the Device Single Use? Yes
Type of Device Usage Unknown
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age43 YR
-
-